LatestFDA Expert Committee Reviews Capricor Therapeutics' Duchenne Muscular Dystrophy Treatment
Cannabis

Athletes Use Cannabis in Silence: What This NFL-Backed Study Revealed

Camila Berriex
Athletes Use Cannabis in Silence: What This NFL-Backed Study Revealed
AnxietyChronic PainInsomnia
Summary

A groundbreaking NFL-backed study reveals that elite and professional athletes in contact sports are using cannabis for pain management, sleep improvement, recovery, and anxiety relief, yet most rely on informal sources like teammates and online research rather than medical professionals. Despite relaxing league policies on cannabis use, athletes continue to keep their usage private due to persistent fears of judgment, career consequences, and potential punishment. The research highlights a critical gap between cannabis policy changes and actual medical support infrastructure in professional sports. For athletes managing chronic pain, insomnia, and anxiety, this finding underscores the urgent need for evidence-based medical guidance and professional oversight in cannabis therapeutic applications.

HIGH TIMES

Originally published on

High Times

By Camila Berriex

Read full article(opens in new tab)

Fetched: July 29, 2026 at 10:03 AM

More news you might be interested in

View all
THC and CBD Reduce Agitation in Advanced Dementia, Study Shows
Cannabis
Alzheimer's Disease

THC and CBD Reduce Agitation in Advanced Dementia, Study Shows

A new clinical trial presented at the Alzheimer's Association International Conference demonstrates that an oral formulation combining THC and CBD significantly reduced agitation in patients with advanced dementia receiving hospice care. The study, while not yet peer-reviewed, offers promising evidence that cannabinoid therapy may help manage behavioral symptoms in end-stage dementia patients who often have limited treatment options. Agitation in advanced dementia is a challenging symptom that frequently requires sedative medications with significant side effects. These findings suggest cannabinoid-based treatments could provide a potentially safer alternative for improving quality of life in vulnerable populations. Further peer-reviewed publication and larger-scale studies are needed to establish optimal dosing and long-term safety profiles.

1 hour ago
Revista Cáñamo
India Leaves Public Cannabis Law Review Without Response as Court Deadline Passes
Cannabis

India Leaves Public Cannabis Law Review Without Response as Court Deadline Passes

India's Delhi High Court deadline of July 23rd for the government to review cannabis restrictions has passed without public resolution. The legal silence exposes significant contradictions in India's cannabis regulations, which inconsistently distinguish between plant parts, authorized medical uses, and criminal penalties. This regulatory ambiguity affects patients seeking access to cannabis-based treatments for various medical conditions. The unresolved review highlights the urgent need for regulatory clarity to align Indian law with emerging medical evidence supporting therapeutic cannabis applications. The delayed response may impact future medical cannabis access and research opportunities in the region.

2 hours ago
Revista Cáñamo
Cannabis Species: Understanding Ruderalis and Hybrid Strains
Cannabis

Cannabis Species: Understanding Ruderalis and Hybrid Strains

Cannabis is typically classified into three main species: sativa, indica, and ruderalis, each with distinct characteristics and therapeutic properties. While federal illegality has limited comprehensive botanical research, cultivators frequently crossbreed top strains from different species to create hybrid varieties with combined effects. These hybrids allow patients and consumers to access customized cannabinoid profiles tailored to specific therapeutic needs. Understanding the differences between pure species and hybrids is essential for informed selection of medical cannabis products in regulated markets like Puerto Rico's medical marijuana program.

6 hours ago
Cannabis Now
Cannabis

Federal Survey Shows Decline in Adolescent Cannabis Use in 2025

The 2025 National Survey on Drug Use and Health (NSDUH) reports a significant decline in annual adolescent cannabis consumption to 8.7%, marking an important shift in youth substance use patterns. This decrease contrasts with evolving consumption trends among adults, suggesting differentiated public health trajectories between age groups. The data provides critical insights for healthcare providers and policymakers developing prevention and intervention strategies. For Puerto Rico's health systems, these findings underscore the importance of evidence-based approaches to adolescent substance use prevention and monitoring. Understanding these epidemiological trends helps inform clinical practices and resource allocation for youth mental health and substance use treatment services.

7 hours ago
Cannabis Magazine